These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21941369)
1. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Ng TL; Leprivier G; Robertson MD; Chow C; Martin MJ; Laderoute KR; Davicioni E; Triche TJ; Sorensen PH Cell Death Differ; 2012 Mar; 19(3):501-10. PubMed ID: 21941369 [TBL] [Abstract][Full Text] [Related]
2. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK. Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756 [TBL] [Abstract][Full Text] [Related]
3. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Avivar-Valderas A; Bobrovnikova-Marjon E; Alan Diehl J; Bardeesy N; Debnath J; Aguirre-Ghiso JA Oncogene; 2013 Oct; 32(41):4932-40. PubMed ID: 23160380 [TBL] [Abstract][Full Text] [Related]
4. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia. Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064 [TBL] [Abstract][Full Text] [Related]
5. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition. Sun D; Liu H; Dai X; Zheng X; Yan J; Wei R; Fu X; Huang M; Shen A; Huang X; Ding J; Geng M Cancer Lett; 2017 Oct; 406():105-115. PubMed ID: 28687354 [TBL] [Abstract][Full Text] [Related]
6. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway. Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363 [TBL] [Abstract][Full Text] [Related]
8. The FoxO-BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress. Lin A; Yao J; Zhuang L; Wang D; Han J; Lam EW; Gan B Oncogene; 2014 Jun; 33(24):3183-94. PubMed ID: 23851496 [TBL] [Abstract][Full Text] [Related]
9. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis. Pan H; Zhong XP; Lee S BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347 [TBL] [Abstract][Full Text] [Related]
10. Antagonistic control of muscle cell size by AMPK and mTORC1. Mounier R; Lantier L; Leclerc J; Sotiropoulos A; Foretz M; Viollet B Cell Cycle; 2011 Aug; 10(16):2640-6. PubMed ID: 21799304 [TBL] [Abstract][Full Text] [Related]
11. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response. Li H; Min Q; Ouyang C; Lee J; He C; Zou MH; Xie Z Biochim Biophys Acta; 2014 Sep; 1842(9):1844-54. PubMed ID: 25016145 [TBL] [Abstract][Full Text] [Related]
12. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Shaw RJ Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654 [TBL] [Abstract][Full Text] [Related]
13. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613 [TBL] [Abstract][Full Text] [Related]
14. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling. Burgos SA; Kim JJ; Dai M; Cant JP Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179 [TBL] [Abstract][Full Text] [Related]
15. Computational analysis of an autophagy/translation switch based on mutual inhibition of MTORC1 and ULK1. Szymańska P; Martin KR; MacKeigan JP; Hlavacek WS; Lipniacki T PLoS One; 2015; 10(3):e0116550. PubMed ID: 25761126 [TBL] [Abstract][Full Text] [Related]
16. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421 [TBL] [Abstract][Full Text] [Related]
17. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex. Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566 [TBL] [Abstract][Full Text] [Related]
18. SUMOylation of AMPKα1 by PIAS4 specifically regulates mTORC1 signalling. Yan Y; Ollila S; Wong IPL; Vallenius T; Palvimo JJ; Vaahtomeri K; Mäkelä TP Nat Commun; 2015 Nov; 6():8979. PubMed ID: 26616021 [TBL] [Abstract][Full Text] [Related]
19. The Pim protein kinases regulate energy metabolism and cell growth. Beharry Z; Mahajan S; Zemskova M; Lin YW; Tholanikunnel BG; Xia Z; Smith CD; Kraft AS Proc Natl Acad Sci U S A; 2011 Jan; 108(2):528-33. PubMed ID: 21187426 [TBL] [Abstract][Full Text] [Related]
20. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase. Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]